An influential FDA advisory committee on Friday said the agency should authorize boosters of Johnson & Johnson's single-shot COVID-19 vaccine to the more than 15 million Americans who have already received the initial dose.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
